North America Respiratory Inhalers Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type [Nebulizers, Metered Dose Inhalers (MDI), and Dry Powder Inhalers], Technology (Manually Operated Inhalers and Digitally Operated Inhalers), and Disease Indication (Asthma, COPD, Pulmonary Arterial Hypertension, and Others)
The North America respiratory inhalers market is expected to grow from US$ 12,747.47 million in 2022 to US$ 17,991.07 million by 2028. It is estimated to register a CAGR of 5.9% from 2022 to 2028.
Growing Adoption of Generic Inhalers Fueling North America Respiratory Inhalers Market Growth
Inhaled medicines, which form a major line of treatment in asthma and COPD patients, are administered through inhalers. Patients suffering from asthma and COPD often need one or more inhalers daily to keep their airways healthy. Therefore, healthcare professionals are concerned about switching between medications as it can negatively impact disease control through low adherence and misuse of aerosol delivery device types. With increasing pressure on healthcare budgets and the simultaneous expiration of patents on established inhalation treatments, several generic replacement products are being manufactured and supplied across the region. Several inhalants that are used to treat asthma include generic formulations, such as albuterol, levalbuterol, ipratropium, budesonide, and fluticasone/salmeterol. The generic inhalers are bioequivalent to the branded versions and have the same effect on the body. The number of generic asthma inhalers continues to increase as patents expire. As more generic drugs are entering the market, increased competition is expected, which, in turn, leads to reduced costs of drugs. Cost reductions can also result from the launch of an “approved generic drug.” Thus, the growing adoption of generic inhalers and asthma medications is improving medication adherence, thereby driving the North America respiratory inhalers market.
North America Respiratory Inhalers Market Overview
The North America respiratory inhalers market is segmented into the US, Canada, and Mexico. The US held the largest share of the North America respiratory inhalers market in 2021. The continuously rising incidence of respiratory disorders is expected to fuel the growth of this market. Currently, asthma and chronic obstructive pulmonary disease (COPD) are major health burdens in the US. Asthma is a chronic inflammatory disorder due to airway narrowing and obstruction. COPD is due to obstruction of airflow from the lungs, which causes chronic inflammatory lung disease. Smoking is the main cause of COPD in the US. The increasing prevalence of smoking in the US is driving the respiratory inhalers market. According to the Centers for Disease Control and Prevention (CDC), in 2020, ~5.0% of adults were diagnosed with COPD, emphysema, or chronic bronchitis in the United States. Approximately 25 million people were affected with asthma, and 14.8 million had COPD. COPD was the fourth leading cause of death in the United States in 2018. Furthermore, ~1 in every 10 infants born in 2020 were preterm births. Thus, the growing prevalence of chronic respiratory disorders and preterm births in the United States is driving the North America respiratory inhalers market.
North America Respiratory Inhalers Market Revenue and Forecast to 2028 (US$ Million)
Get more information on this report :
North America Respiratory Inhalers Market Segmentation
The North America respiratory inhalers market is segmented based on product type, technology, disease indication, and country.
Based on product type, the North America respiratory inhalers market is segmented into nebulizers, metered dose inhalers (MDI), and dry powder inhalers. The dry powder inhalers segment held the largest share of the North America respiratory inhalers market in 2022.
Based on technology, the North America respiratory inhalers market is bifurcated into manually operated inhalers and digitally operated inhalers. The manually operated inhalers segment held a larger share of the North America respiratory inhalers market in 2022.
Based on disease indication, the North America respiratory inhalers market is segmented into asthma, COPD, pulmonary arterial hypertension, and others. The asthma segment held the largest share of the North America respiratory inhalers market in 2022.
Based on country, the North America respiratory inhalers market has been categorized into the US, Canada, and Mexico. The US dominated the North America respiratory inhalers market in 2022.
AstraZeneca Plc; Beximco Pharmaceuticals Ltd.; Boehringer Ingelheim International GmbH; Cipla Ltd; GSK Plc; Koninklijke Philips NV; OMRON Corp; OPKO Health, Inc; PARI Respiratory Equipment, Inc.; and Teva Pharmaceutical Industries Ltd are the leading companies operating in the North America respiratory inhalers market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Respiratory Inhalers Market – by Product Type
1.3.2 North America Respiratory Inhalers Market – by Technology
1.3.3 North America Respiratory Inhalers Market – by Disease Indication
1.3.4 North America Respiratory Inhalers Market – by Country
2. North America Respiratory Inhalers Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Respiratory Inhalers Market – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Expert’s Opinion
5. North America Respiratory Inhalers Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Cases of Respiratory Disorders
5.1.2 Growing Adoption of Generic Inhalers
5.2 Market Restraints
5.2.1 Lack of Early Diagnosis and High Cost of Inhalers
5.3 Market Opportunities
5.3.1 Increasing Adoption of Smart Inhalers Technology
5.4 Future Trends
5.4.1 Increasing Product Development Activities
5.5 Impact Analysis
6. Respiratory Inhalers Market – North America Analysis
6.1 North America Respiratory Inhalers Market Revenue Forecast and Analysis
7. North America Respiratory Inhalers Market – Revenue and Forecast to 2028 – by Product Type
7.1 Overview
7.2 North America Respiratory Inhalers Market Revenue Share, by Product, 2021 & 2028 (%)
7.3 Dry Powder Inhalers
7.3.1 Overview
7.3.2 Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Multi-Dose Dry Powder Inhalers
7.3.3.1 Overview
7.3.3.2 Multi-Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Single Dose Dry Powder Inhalers
7.3.4.1 Overview
7.3.4.2 Single Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Metered Dose Inhalers
7.4.1 Overview
7.4.2 Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Pressured Metered Dose Inhalers
7.4.3.1 Overview
7.4.3.2 Pressured Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Connected Metered Dose Inhalers
7.4.4.1 Overview
7.4.4.2 Connected Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Nebulizers
7.5.1 Overview
7.5.2 Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.3 Compressed Air Nebulizers
7.5.3.1 Overview
7.5.3.2 Compressed Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.4 Mesh Air Nebulizers
7.5.4.1 Overview
7.5.4.2 Mesh Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.5 Ultrasonic Air Nebulizers
7.5.5.1 Overview
7.5.5.2 Ultrasonic Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Respiratory Inhalers Market Analysis and Forecast to 2028 – by Technology
8.1 Overview
8.2 North America Respiratory Inhalers Market, by Technology 2021 & 2028 (%)
8.3 Manually Operated Inhalers
8.3.1 Overview
8.3.2 Manually Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Digitally Operated Inhalers
8.4.1 Overview
8.4.2 Digitally Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Respiratory Inhalers Market Analysis and Forecast to 2028 – by Disease Indication
9.1 Overview
9.2 North America Respiratory Inhalers Market, by Disease Indication, 2021 & 2028 (%)
9.3 Asthma
9.3.1 Overview
9.3.2 Asthma: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.4 COPD
9.4.1 Overview
9.4.2 COPD: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Pulmonary Arterial Hypertension
9.5.1 Overview
9.5.2 Pulmonary Arterial Hypertension: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Respiratory Inhalers Market – Revenue and Forecast to 2028 – Country Analysis
10.1 Overview
10.1.1 North America: Respiratory Inhalers Market, by Country, 2021 & 2028 (%)
10.1.1.1 US: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.2 US: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3 US: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.3.1 US: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.3.2 US: Respiratory Inhalers Market, by Metered Dose Inhalers, 2019–2028 (US$ Million)
10.1.3.3 US: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.4 US: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.5 US: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.1.5.1 Canada: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.5.1.1 Overview
10.1.5.1.2 Canada: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.5.1.3 Canada: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.5.1.3.1 Canada: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.5.1.3.2 Canada: Respiratory Inhalers Market, by Metered Dose Inhalers, 2019–2028 (US$ Million)
10.1.5.1.3.3 Canada: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.5.1.4 Canada: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.5.1.5 Canada: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.1.5.2 Mexico: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.5.2.1 Overview
10.1.5.2.2 Mexico: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.5.2.3 Mexico: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.5.2.3.1 Mexico: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.5.2.3.2 Mexico: Respiratory Inhalers Market, by Metered Dose Inhalers, 2019–2028 (US$ Million)
10.1.5.2.3.3 Mexico: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.5.2.4 Mexico: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.5.2.5 Mexico: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 AstraZeneca Plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Beximco Pharmaceuticals Ltd.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Boehringer Ingelheim International GmbH
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Cipla Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 GSK Plc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Koninklijke Philips NV
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 OMRON Corp
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 PARI Respiratory Equipment, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Teva Pharmaceutical Industries Ltd
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 OPKO Health, Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. US Respiratory Inhalers Market, by Product Type– Revenue and Forecast to 2028 (US$ Million)
Table 2. US Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 3. US Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 4. US Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 5. US Respiratory Inhalers Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 6. US Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada Respiratory Inhalers Market, by Product Type– Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Respiratory Inhalers Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico Respiratory Inhalers Market, by Product Type– Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico Respiratory Inhalers Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 19. Recent Inorganic Growth Strategies
Table 20. Recent Organic Growth Strategies
Table 21. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Respiratory Inhalers Market Segmentation
Figure 2. North America Respiratory Inhalers Market, by Country
Figure 3. North America Respiratory Inhalers Market Overview
Figure 4. North America Respiratory Inhalers Market, By Product
Figure 5. North America Respiratory Inhalers Market, By Country
Figure 6. North America: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. North America Respiratory Inhalers Market: Impact Analysis of Drivers and Restraints
Figure 9. North America Respiratory Inhalers Market – Revenue Forecast and Analysis
Figure 10. North America Respiratory Inhalers Market Revenue Share, by Product, 2021 & 2028 (%)
Figure 11. Dry Powder Inhalers: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Multi-Dose Dry Powder Inhalers: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Single Dose Dry Powder Inhalers: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Metered Dose Inhalers: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Pressured Metered Dose Inhalers: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Connected Metered Dose Inhalers: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Nebulizers: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Compressed Air Nebulizers: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Mesh Air Nebulizers: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Ultrasonic Air Nebulizers: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. North America Respiratory Inhalers Market, by Technology 2021 & 2028 (%)
Figure 22. Manually Operated Inhalers: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Digitally Operated Inhalers: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. North America Respiratory Inhalers Market, by Disease Indication, 2021 & 2028 (%)
Figure 25. Asthma: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. COPD: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Pulmonary Arterial Hypertension: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Others: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. North America: Respiratory Inhalers Market, by Key Country – Revenue (2021) (US$ Million)
Figure 30. US: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Canada: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Mexico: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
- AstraZeneca Plc
- Beximco Pharmaceuticals Ltd.
- Boehringer Ingelheim International GmbH
- Cipla Ltd
- GSK Plc
- Koninklijke Philips NV
- OMRON Corp
- OPKO Health, Inc
- PARI Respiratory Equipment, Inc.
- Teva Pharmaceutical Industries Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America respiratory inhalers market.
- Highlights key business priorities to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America respiratory inhalers market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the respiratory inhalers market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution